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We have investigated the photoprotective properties
of induced pigmentation using erythema and epider-
mal DNA photodamage as endpoints. Previously
unexposed buttock skin of 12 young, healthy adults
(six skin type II and six skin type IV) was exposed
daily (Monday to Friday) for 2 wk (days 1±12) with
0.65 minimal erythema dose of solar simulated radi-
ation. Mean skin type IV minimal erythema dose
was 1.8-fold greater than for skin type II. Compared
to skin type II, solar simulated radiation treatments
produced less erythema and more tanning in skin
type IV. To assess DNA photodamage, biopsies were
taken and prepared for paraf®n sections that were
stained with a monoclonal antibody for thymine
dimers. Thymine dimers were quanti®ed by image
analysis. The single exposure data (0.65 and 2 mini-
mal erythema dose) showed that DNA damage was
related to physical dose (J per cm2) independent of
skin type. Our data also showed that DNA photo-
damage accumulates in both skin types with
repeated, suberythemal doses of solar simulated radi-
ation. On day 12, there were more thymine dimers
in skin type IV than skin type II, again indicating
that physical rather than biologic dose determines
the level of DNA damage. Comparisons on days 12
and 19, however, showed a much greater loss of
thymine dimers in skin type IV, suggesting better
thymine dimer repair. Protection factors for
erythema and thymine dimers were calculated and
shown to be about 2 in both skin types. This pro-
vides further indirect evidence that DNA is a
chromophore for erythema, but also suggests that a
tan may not be the major factor in natural photo-
protection. Key words: melanogenesis/protection factor/
thymine dimers. J Invest Dermatol 118:825±829, 2002
T
he skin is repeatedly exposed to solar ultraviolet
radiation (UVR), which results in various deleterious
effects including photoageing and skin cancer (Green
et al, 1992). Constitutively pigmented skin is more
resistant to sunburn and skin cancer than ``white'' skin
(Kaidbey et al, 1979). Within ``white'' skin types, epidemiologic
data show a higher incidence of skin cancer in fair skinned
individuals who burn easily and do not tan readily (skin types I and
II). UVR induces keratinocyte DNA mutations at speci®c sites
such as adjacent pyrimidine bases (cytosine or thymine) and
generates a distinct ``signature'' mutation pattern, namely C ® T or
C=C ® T=T at dipyrimidine sites (Wikonkal and Brash, 1999). It
has been shown that more than 50% of skin basal cell carcinomas
contain UVR-induced ``signature'' mutations at p53 sites that
appear to be clustered in hotspots (Ziegler et al, 1993). The
mutation of genes that lead to a lack of nucleotide excision repair of
DNA photolesions in xeroderma pigmentosum patients indicates a
strong association between DNA photodamage and skin cancer
(Kraemer et al, 1994; van Steeg and Kraemer, 1999).
The skin responds to repeated exposure by tanning (especially in
skin types III and IV who tan readily and burn rarely), which is the
result of melanogenesis and associated stratum corneum thickening.
Tanning is widely believed to be a photoprotective response of
UVR-exposed skin, which decreases damage from subsequent
UVR exposure (Kollias et al, 1991; Mawn and Fleischer, 1993;
McGinley et al, 1998). Much of the work to date on natural
photoprotection, however, is based on constitutive pigmentation
(McFadden et al, 1961; Young et al, 1985; Lookingbill et al, 1995;
Lock-Andersen et al, 1997). It has further been suggested that the
signi®cance of stratum corneum in photoprotection may be greater
in fair skinned individuals than in pigmented individuals (de Fine
et al, 1997), especially in albino or vitiliginous skin where the
stratum corneum may represent the only source of protection.
Some of our previous human studies show that repeated exposure
of skin types I/II to suberythemal solar simulated radiation (SSR)
affords no protection against DNA photodamage from a subsequent
2 minimal erythema dose (MED) of SSR. Modest photoprotection
[protection factor (PF) of 2±3], however, was seen in skin types III/
IV (who developed a good tan) (Young et al, 1991; Potten et al,
1993). DNA damage was measured in these studies either using an
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indirect measurement of DNA damage (unscheduled DNA
synthesis) or directly using a monoclonal antibody to thymine
dimers (T=T). There was good correlation between SSR dose and
the levels of T=T in epidermal nuclei and the levels of T=T also
correlated well with the levels of unscheduled DNA synthesis.
In this study we have investigated the photoprotective effects of
tanning induced by repeated daily suberythemal SSR exposure.
These tanning treatments were carried out over a 2 wk period,
which may be considered as a ``simulated beach holiday exposure''
during which, for example, sunscreens may have been used to
minimize sunburn. We have selected skin types II and IV and the
photoprotection endpoints we have used are the MED and DNA
damage (T=T, a class of cyclobutane pyrimidine dimer). These
studies have enabled us to determine PF that are analogous to the
widely used sun protection factors (SPF) used to classify the
photoprotective properties on sunscreens.
We have shown in unpublished pilot studies that DNA
photodamage accumulates in skin types II and III with repeated,
suberythemal doses of SSR. The accumulation of DNA photo-
damage at suberythemal UVB exposures has also been shown in
uninvolved human skin of psoriatics undergoing photochemo-
therapy (Bataille et al, 2000). This is an important factor to consider
as the accumulation of unrepaired DNA damage may have serious
implications for skin cancer risk.
In this study we have investigated two factors concerned with
the tanning response in different human skin types: ®rst, the level of
photoprotection a tan offers against erythema and DNA photo-
damage, and second the accumulation and repair of DNA damage
in the acquisition of a tan.
MATERIALS AND METHODS
Volunteers The local ethics committee approved the study. Twelve
healthy young people were selected on the basis of their constitutive skin
color and a questionnaire on their responses to solar exposure. According
to the Fitzpatrick classi®cation (Fitzpatrick, 1988) six volunteers were
skin type II (burns easily, tans with dif®culty) and six were skin type IV
(tans well, burns rarely). Mean age was 24 y 6 7 (SD). Eight volunteers
were male and four were female. All volunteers gave informed consent.
UVR source and dosimetry SSR was obtained from a 1000 W
xenon arc solar simulator (Oriel, U.K.). The spectrum of this source has
been previously published (Sheehan et al, 1998). The irradiance over the
295±400 nm range was determined with a double-monochromator
spectroradiometer (Bentham Instruments, Reading, U.K.) that had been
calibrated against a deuterium source measured by the National Physics
Laboratory (Teddington, Middlesex, U.K.). These data were used to
calibrate a wide-band thermopile radiometer (Medical Physics, Dryburn
Hospital, Durham, U.K.), which was used for routine calculation of
exposure dose (295±400 nm) expressed as J per cm2. Multiplication of
the SSR and U.K. (51°N) solar spectra with the Commission
Internationale de L'EÂ clairage (CIE) erythema action spectrum (McKinlay
and Diffey, 1987) shows that 92% and 81%, respectively, of the effective
erythema energy is UVB (280±320 nm).
Study protocol All exposures were given to previously unexposed
buttock skin. The 24 h just perceptible MED was determined by a
geometric exposure series of eight (1 cm 3 1 cm) sites using a 25%
incremental dose series. Duplicate 6 3 5 cm sites were exposed daily
(Monday to Friday) for two consecutive weeks (days 1±12) with 0.65
individual MED of SSR (pilot studies had shown that this was a dose
that was tolerated in skin type II without excessive cumulative
erythema). In order to assess the erythema PF offered by the SSR-treated
site, 1 wk after the ®nal SSR treatment (days 18 and 19) the 24 h MED
was assessed on one 0.65 MED daily treated site and reassessed on one
adjacent nontreated site. On day 19 biopsies were taken from (i) a
nontreated site, (ii) an SSR-treated site, (iii) an SSR-treated site
immediately following a 2 MED exposure, (iv) an untreated site
immediately after 2 MED, and (v) an untreated site that had received a
single 0.65 MED SSR exposure. A biopsy was also taken from (vi) a
treated site immediately after the last tanning treatment (end of week 2)
in order to assess DNA photodamage induced by the chronic exposure.
Biopsy (vi) shows how much DNA photodamage is induced by the
10 3 0.65 MED exposures. Biopsy (ii) shows how much residual DNA
damage remains from the repeat exposures 1 wk later. Combined, the
data from biopsies (vi) and (ii) give an indication of DNA photodamage
repair or loss of lesions by desquamation. By comparing data from
biopsies (iii) and (iv), we obtained a PF for DNA photodamage.
Evaluation of erythema and tanning during study Exposure sites
were assessed daily before each SSR exposure for erythema and tanning
by eye and with a re¯ectance meter (Dia-Stron, Andover, U.K.) during
the tanning treatment and on days 18 and 19. To obtain background
corrected data, background erythema and tanning readings from
proximal, untreated sites were subtracted from the erythema and tanning
readings from treated sites.
Assessment of T=T Biopsies taken as described above were processed
for analysis of T=T. The details have been published elsewhere (Potten
et al, 1993). Brie¯y, 3 mm paraf®n sections were cut and immunostained
with a monoclonal antibody for T=T (TDM-1) (Mori et al, 1991),
followed by a DAB-peroxidase immune reaction that gives a brown
nuclear coloration. Nuclei were counterstained with thionine. The
sections were analyzed quantitatively using the Discovery automated
image analysis system (Beckton Dickinson, Leiden, The Netherlands).
T=T assessments were made over all epidermal layers as we have
previously shown no quantitative differences between the basal and
suprabasal layers exposed to SSR. In each volunteer, the speci®c
background mean optical density per nucleus (i.e., T=T levels from a
sample of biopsy obtained from non-SSR exposed skin) was subtracted
from the mean optical density of the SSR-exposed sites.
Data analyses and statistical methods For each volunteer, erythema
and MED readings from exposed and nonexposed sites as well as biopsies
from exposed and nonexposed sites were taken as described. In each case
the ratio of MED or T=T level on pre-exposed sites to MED or T=T
on nonexposed sites was calculated and expressed as the PF. The PF
represents an increase in protection against SSR-induced erythema or
DNA photodamage following repeat, suberythemal exposure. The PF
was calculated using the same approach as that for the determination of
SPF. Thus, per person, the PF for erythema and DNA damage on the
chronically exposed sites was determined using the expression
PF = (MED or T=T value on treated site)/(MED or T=T value on a
nontreated site).
In each case, mean and SD were calculated for skin type II and skin
type IV separately. Single paired t tests (two-tailed) were carried out to
compare values from exposed and nonexposed sites.
RESULTS
The tanning treatment results in more erythema in skin type
II and more tanning in skin type IV At the end of week 3
(day 19), the daily tanning treatment resulted in a light tan in skin
types II and a light-moderate tan in skin types IV. The differences
in quantitative data re¯ect these semiquantitative observations. The
onset and duration of erythema and tanning in response to SSR
treatment are shown in Figs 1(a) and 1(b), respectively. All
readings were background corrected and so are relative to
proximal, non-SSR-exposed sites. The degree of tanning was
greater in skin type IV. In skin type II, there is a cumulative
erythema peak on day 5, which matched observations by eye. The
erythema is less prominent by day 12 and was not perceptible to the
naked eye by day 19. In all cases, skin type IV showed a similar
pattern but with lower levels of erythema and more evident
tanning.
With both skin types there is a steady increase in melanin content
as the study progressed. With skin type II volunteers, however, the
melanin appears to decrease (not statistically signi®cant, p = 0.38)
during the ®rst week and steadily rises during the second week. We
have previously reported this in humans and mice (Kipp et al, 1998;
Sheehan et al, 1998). The reasons for this are not known.
DNA damage is related to physical SSR dose when adminis-
tered as a single exposure or as repeat exposures Figure 2
shows that DNA damage increases with increasing SSR dose.
Figure 2(a) shows the epidermal DNA damage induced by single
exposures of 0.65 MED or 2 MED SSR in skin types II and IV.
When biopsies are taken immediately after exposure, the data
indicate that the amount of epidermal DNA damage per single
biologic dose (0.65 MED or 2 MED) is related to the physical dose.
Figure 2(b) shows the epidermal DNA damage induced by repeat
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exposures of 0.65 MED SSR in skin types II and IV when biopsies
were taken immediately after the last tanning treatment dose.
Cumulatively, the two skin type groups got the same biologic dose
(10 daily exposures of 0.65 MED), but the data show that the
higher amount of DNA damage in skin type IV appears to be
related to higher physical dose.
Epidermal DNA damage is more persistent in skin type II
than in skin type IV Figure 3 shows the levels of epidermal
DNA photodamage immediately after the last tanning treatment
and the levels of damage in those tanned sites 1 wk later.
Figure 3(a) shows means of each skin type group. Figure 3(b)
shows the individual volunteer data. In skin types IV, there was a
signi®cant reduction (68.9%) in the amount of DNA damage in the
tanned sites after 1 wk (p = 0.02). Skin type II displayed a smaller
reduction (37.3%) in the amount of DNA damage after 1 wk but
this was not signi®cant (p = 0.18). Skin type IV had higher levels of
DNA damage induced by the tanning protocols than skin type II
(although this was not signi®cant, p = 0.1) but generally repaired
the damage better over the period of 1 wk.
The PF for DNA photodamage and erythema are the same
and are independent of skin type Skin type IV showed slightly
higher PF than skin type II for both erythema and DNA
photodamage but the difference was not signi®cant (p = 0.3 for
erythema and p = 0.23 for DNA). The PF data for erythema and
DNA damage are shown in Fig 4. The initially assessed mean
MED value did not change on the second assessment on untreated
skin. There was no signi®cant difference between the PF for DNA
and erythema in skin type II or IV (p = 0.99 and p = 0.83,
respectively).
DISCUSSION
We have assessed the photoprotective properties of induced
tanning in skin types II and IV using erythema and T=T as
endpoints. Our protocol simulated ``sensible tanning'' with daily
suberythemal exposure to SSR and was designed to minimize the
effects of erythema accumulating after a few exposures. During the
SSR treatment there was a clear difference in response between the
two skin types. As expected, skin types II showed more erythema
than skin types IV who in turn showed a better tanning response.
One week after the last tanning treatment, SSR-exposed and
nontreated sites were challenged with 2 MED SSR and PF were
determined for erythema and T=T. The results (Fig 4) showed
that in all cases the PF were in the region of 2±3. The values were
slightly higher in skin type IV but the differences were not
signi®cant. The similarity of the PF against erythema and T=T
supports the hypothesis that DNA is a major chromophore for
erythema as suggested by Young et al (1998, 2000). The PF of
about 2 against erythema con®rm our earlier studies in skin types II
and III (Sheehan et al, 1998). The lack of difference between skin
types II and IV suggests that the protection afforded by the
treatment was not dependent on the level of tan as there was, as
expected, a marked difference in the tanning response of the two
skin types. It has been reported that UVR-induced stratum
corneum thickening is important in photoprotection (Kaidbey and
Kligman, 1978; Gniadecka et al, 1996). We did not assess stratum
corneum thickening in this study, but we have previously shown
no skin-type-dependent difference in the number of stratum
corneum layers after repeated daily exposure to suberythemal SSR
Figure 2. DNA photodamage is related to SSR dose (J per cm2)
irrespective of skin type. Although skin types II and IV received the
same biologic SSR exposures (based on MED) the latter had higher
physical doses (J per cm2) because of greater MEDs. (a) Acute T=T
follow a dose±response that indicates a plateau with higher acute SSR
doses. (b) Repeated SSR exposure results in more cumulative T=T in
skin type IV than II. MOD±bg is the background corrected level of
T=T. The error bars represent the SD.
Figure 1. Repeat SSR treatment results in more erythema in skin
type II and more tanning in skin type IV. Mean D erythema (a) and
mean D melanin (b) assessments made daily during weeks 1 and 2 on
SSR-treated skin from six skin type II and six skin type IV volunteers.
Assessments of erythema and melanin made on Friday of week 3 are also
shown. Data are background corrected against proximal, non-SSR-
exposed skin. Error bars are SD.
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(Young et al, 1988). We have previously shown, however, that
tape-stripping to remove the stratum corneum had little effect on
the protective properties of a tan against erythema in skin types II
and III (Sheehan et al, 1998).
The volunteers received the same cumulative biologic dose (6.5
MED) but the skin type IV group received a higher cumulative
physical dose (50 J per cm2 6 9) than those of skin type II (38 J per
cm2 6 8) As shown in Fig 2(b), this resulted in higher levels of
T=T in skin type IV when the skin was assessed on day 12. For a
given single exposure dose there was also more T=T in skin type
IV. This was more apparent with the 0.65 MED than the 2 MED
that seems to be in a plateau region as we have previously reported
with SSR (Young et al, 1996). These results suggest that untanned
skin in sun-sensitive skin types is not inherently more sensitive to
cyclobutane pyrimidine dimer formation as has been previously
reported (Xu et al, 2000) but that T=T induction is a simple
function of UVR dose independent of skin type, even with the
development of pigmentation as was the case with skin type IV.
We have previously shown slow T=T repair in skin type I/II
after a single exposure of 2 MED SSR (Young et al, 1996).
Furthermore, we did not detect any skin-type-dependent differ-
ences in T=T repair after a single exposure to 2 MED SSR (Young
et al, 1996) although we did see large interpersonal variation.
Comparisons of samples at the end of the SSR treatment period and
1 wk post-SSR, however, show a 68.9% reduction in skin type IV
compared with a 37.3% reduction in skin type II, despite the fact
that skin type IV had almost 2-fold more T=T at the end of the
SSR treatment period. This strongly suggests that repeat SSR
exposure has induced DNA repair in skin type IV but not skin
type II.
This proposed greater T=T repair in skin type IV is in
accordance with the hypothesis of Gilchrest and Eller (1999)
whose data suggest that DNA excision fragments or DNA repair
intermediates are a trigger for melanogenesis. It has also been
suggested that DNA damage stimulates pigmentation through
upregulation of tyrosinase levels and that tanning is part of the
eukaryotic SOS response (Eller et al, 1997). Our data suggest that
this response may only occur in skin types that tan well and that this
may be the reason that they are more resistant to skin cancer rather
than the protective properties of a tan per se.
We have previously shown that the erythemal response to
repeated suberythemal SSR is greater and more persistent in skin
type II than in skin type III (Sheehan et al, 1998) and in this study
we have seen the same trend between skin type II and IV. It has
been suggested by Holmes et al (1997) and others (Jung et al, 1980;
Aubin et al, 1989) that persistent erythema may be an independent
risk factor for the development of skin cancer. Wilson et al (1981)
have shown that prolonged erythema from a single exposure is
related to skin type. The cumulative response to repeated
suberythemal exposures may be more relevant to risk assessment
than a single exposure response as the former is more relevant to a
real-life situation. We believe that DNA is the chromophore for
erythema (Young et al, 1998), which would mean that erythema is
the consequence of DNA photolesions such as cyclobutane
pyrimidine dimers. It is possible that the persistence of erythema
in skin types I (Young et al, 1991) and II is due to the lack of DNA
repair in these skin types compared with skin types III and IV.
Here, it is interesting to note that skin-cancer-prone xeroderma
pigmentosum patients who lack DNA repair capacity also show
persistent erythema (Berg et al, 1998).
The widespread and popular belief that a tan is photoprotective is
often used to justify tanning. Our study shows that the protection
afforded by repeat low dose SSR exposure is modest and does not
seem to be related to tanning per se. Using tanning protocols with
higher daily doses from a different SSR source, we have previously
reported a lack of any protection from SSR-induced epidermal
DNA damage in skin types I and II but PF of about 2 in skin types
III and IV (Young et al, 1991; Potten et al, 1993). The low level of
photoprotection that we have observed suggests that any photo-
protective bene®t afforded by a tan is outweighed by the
photodamage incurred in its acquisition, especially in skin type II.
It should be remembered, however, that our study sites had not
previously been exposed to UVR. More constant exposure, along
with time, may alter any risk±bene®t assessment. A PF of 2 may be
considerable over a lifetime, reducing effective UVR dose by 50%,
if the tan can be maintained with lower levels of solar exposure,
especially in white skin types that tan well. The stimulation of
Figure 4. The PF for DNA photodamage and erythema are the
same. Skin type IV showed slightly higher values than skin type II but
the differences were not signi®cant for either endpoint or between skin
types (p > 0.5). These data support the hypothesis that DNA is a
chromophore for erythema. The error bars represent the SD.
Figure 3. DNA repair 1 wk postirradiation is better in skin type
IV than skin type II. DNA damage levels in skin type IV (mean =
235 6 112) were higher than in skin type II (mean = 129 6 53). One
week after the exposure period, however, there was no change in skin
type II (p = 0.18) whereas there was a signi®cant reduction in skin type
IV (p = 0.02). (a) The mean data; (b) the individual data. The individual
data show evidence of one skin type IV that did not accumulate DNA
damage during the treatment and one skin type II that repaired well.
MOD±bg is the background corrected level of T=T. The error bars
represent the SD.
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DNA repair by regular low level UVR exposure may be an
important factor to consider in risk assessment and public health
campaigns. The cumulative DNA damage incurred on acquiring
and maintaining a tan, however, remains an important risk and
must be considered very carefully.
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